Recently our country has adopted the normative act for obtaining the anti-Covid vaccine from China, while the previous day hosted 10,000 doses of the Russian "Sputnik V" vaccine.
Even for new vaccines people are skeptical, wanting to know more about their effectiveness and safety. Chief of the Department of Infectious Diseases at the Institute of Public Health Silva Bino has given more details about new vaccines by emphasizing the importance of mass vaccination.
"This vaccine (Chinese vaccine) has begun the third phase trials since July 2020 in China, has also begun in Brazil, Turkey, Chile, which have also estimated disease efficiency at 50.6% and went 100% to the worst cases and 83% for cases seeking hospitalization. The goal of vaccines is to reduce mortality and hospital stretching. This is not about efficiency, but such a thing is also related to preventing spread. This is a vaccine used by Turkey, Thailand, the Philippines, Chile, Mexico, China Brazil, Azerbaijan and Asian countries.
To be sure of population use we have data from Turkey and what is important is that we are in the race with the time regarding vaccination. For this we must be sure of the vaccine and by passing the first and second phases this is a vaccine that has good data for use."
Despite the security, Bino added that they should be ready for any kind of side effect it can give should be prepared.
"Also we must be prepared for any side effects it can deliver. It is important that vaccines help immunize our population. AstraZeneca is a vector vaccine, Sputnik V, which distinguishes that there are two types of vaccines and we are getting a vaccine with immune virus."
Burimi: Abc News
